March 05, 2015 2:37 PM ET

Pharmaceuticals

Company Overview of Cerexa, Inc.

Company Overview

Cerexa, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective therapies for the treatment of antibiotic-resistant infections. It provides Ceftaroline AcetateCeftaroline, an injectable cephalosporin that is used for the treatment of bacterial infections caused by gram-positive and gram-negative pathogens. The company was founded in 2005 and is based in Alameda, California.

2100 Franklin Street

Suite 900

Oakland, CA 94612

United States

Founded in 2005

Phone:

510-285-9200

Fax:

510-285-9299

Key Executives for Cerexa, Inc.

Vice President of Drug Development
Age: 54
Vice President of Clinical Sciences
Age: 54
Vice President of Clinical Microbiology
Executive Director of Project Management
Vice President of Clinical Operations
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
airPharma, LLC United States
HMR Pharma Inc. United States
Sirius Laboratories, Inc. United States
Inviragen, Inc. United States
Semafore Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cerexa, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.